Nifty
Sensex
:
:
17168.10
58205.40
16.20 (0.09%)
-9.19 (-0.02%)

Pharmaceuticals & Drugs - API

Rating :
38/99

BSE: 524164 | NSE: IOLCP

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,646.40
  • 15.83
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,549.16
  • 1.43%
  • 1.12

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 43.69%
  • 19.77%
  • 30.91%
  • FII
  • DII
  • Others
  • 2.37%
  • 0.02%
  • 3.24%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.32
  • 17.30
  • 4.86

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.15
  • 16.48
  • -14.89

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 59.14
  • 43.00
  • -22.89

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 8.89
  • 9.61
  • 9.80

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.53
  • 2.53
  • 2.55

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 9.36
  • 5.92
  • 6.32

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Dec 22
Dec 21
Var%
Sep 22
Sep 21
Var%
Jun 22
Jun 21
Var%
Mar 22
Mar 21
Var%
Net Sales
523.48
0.00
0
541.41
0.00
0
565.01
0.00
0
572.49
0.00
0
Expenses
480.79
0.00
0
509.51
0.00
0
509.22
0.00
0
527.36
0.00
0
EBITDA
42.69
0.00
0
31.90
0.00
0
55.79
0.00
0
45.13
0.00
0
EBIDTM
8.15%
0.00%
5.89%
0.00%
9.87%
0.00%
7.88%
0.00%
Other Income
6.65
0.00
0
5.07
0.00
0
5.16
0.00
0
6.93
0.00
0
Interest
4.70
0.00
0
3.51
0.00
0
3.38
0.00
0
2.34
0.00
0
Depreciation
11.75
0.00
0
11.32
0.00
0
10.98
0.00
0
11.01
0.00
0
PBT
32.89
0.00
0
22.14
0.00
0
46.59
0.00
0
38.71
0.00
0
Tax
9.10
0.00
0
6.23
0.00
0
11.92
0.00
0
8.95
0.00
0
PAT
23.79
0.00
0
15.91
0.00
0
34.67
0.00
0
29.76
0.00
0
PATM
4.54%
0.00%
2.94%
0.00%
6.14%
0.00%
5.20%
0.00%
EPS
4.05
0.00
0
2.71
0.00
0
5.91
0.00
0
5.07
0.00
0

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 22
Net Sales
-
2,184.02
Net Sales Growth
-
 
Cost Of Goods Sold
-
1,570.51
Gross Profit
-
613.51
GP Margin
-
28.09%
Total Expenditure
-
1,925.73
Power & Fuel Cost
-
78.18
% Of Sales
-
3.58%
Employee Cost
-
141.30
% Of Sales
-
6.47%
Manufacturing Exp.
-
36.86
% Of Sales
-
1.69%
General & Admin Exp.
-
5.12
% Of Sales
-
0.23%
Selling & Distn. Exp.
-
66.84
% Of Sales
-
3.06%
Miscellaneous Exp.
-
26.92
% Of Sales
-
1.23%
EBITDA
-
258.29
EBITDA Margin
-
11.83%
Other Income
-
32.04
Interest
-
8.29
Depreciation
-
43.26
PBT
-
238.78
Tax
-
57.18
Tax Rate
-
25.43%
PAT
-
167.67
PAT before Minority Interest
-
167.67
Minority Interest
-
0.00
PAT Margin
-
7.68%
PAT Growth
-
 
EPS
-
28.56

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 22
Shareholder's Funds
1,392.28
Share Capital
58.71
Total Reserves
1,333.57
Non-Current Liabilities
56.62
Secured Loans
0.00
Unsecured Loans
0.00
Long Term Provisions
3.01
Current Liabilities
575.29
Trade Payables
409.29
Other Current Liabilities
54.02
Short Term Borrowings
42.75
Short Term Provisions
69.23
Total Liabilities
2,024.19
Net Block
560.64
Gross Block
762.84
Accumulated Depreciation
202.20
Non Current Assets
881.48
Capital Work in Progress
105.20
Non Current Investment
0.00
Long Term Loans & Adv.
6.14
Other Non Current Assets
209.50
Current Assets
1,142.71
Current Investments
2.37
Inventories
409.89
Sundry Debtors
469.80
Cash & Bank
139.99
Other Current Assets
120.66
Short Term Loans & Adv.
89.67
Net Current Assets
567.42
Total Assets
2,024.19

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 22
Cash From Operating Activity
93.05
PBT
224.85
Adjustment
33.12
Changes in Working Capital
-102.34
Cash after chg. in Working capital
155.63
Interest Paid
0.00
Tax Paid
-62.58
Other Direct Exp. Paid
0.00
Extra & Other Items
0.00
Cash From Investing Activity
-120.19
Net Fixed Assets
Net Investments
Others
Cash from Financing Activity
-1.64
Net Cash Inflow / Outflow
-28.78
Opening Cash & Equivalents
32.34
Closing Cash & Equivalent
3.56

Financial Ratios

Standalone /

Consolidated
Description
Mar 22
Book Value (Rs.)
237.15
ROA
8.28%
ROE
12.04%
ROCE
16.25%
Fixed Asset Turnover
2.86
Receivable days
78.51
Inventory Days
68.50
Payable days
95.12
Cash Conversion Cycle
51.89
Total Debt/Equity
0.03
Interest Cover
28.12

News Update:


  • IOL Chemicals and Pharmaceuticals reports 40% fall in Q3 net profit
    8th Feb 2023, 14:07 PM

    Total income of the company decreased 6.01% at Rs 530.12 crore for Q3FY23

    Read More
  • IOL Chem & Pharma - Quarterly Results
    7th Feb 2023, 17:49 PM

    Read More
  • IOL Chemicals and Pharmaceuticals incorporates wholly owned subsidiary in UK
    1st Feb 2023, 15:17 PM

    The WOS is incorporated to carry on the business in the field of Pharmaceuticals/Chemicals

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.